Suppr超能文献

医疗保险受益人的处方药使用所带来的医疗成本抵消。

Medical cost offsets from prescription drug utilization among Medicare beneficiaries.

作者信息

Roebuck M Christopher

机构信息

M. Christopher Roebuck, PhD, MBA, 11350 McCormick Rd., Executive Plaza II, Ste. 705, Hunt Valley, MD 21031, USA.

出版信息

J Manag Care Spec Pharm. 2014 Oct;20(10):994-5. doi: 10.18553/jmcp.2014.20.10.994.

Abstract

This brief commentary extends earlier work on the value of adherence to derive medical cost offset estimates from prescription drug utilization. Among seniors with chronic vascular disease, 1% increases in condition-specific medication use were associated with significant (P  less than  0.001) reductions in gross nonpharmacy medical costs in the amounts of 0.63% for dyslipidemia, 0.77% for congestive heart failure, 0.83% for diabetes, and 1.17% for hypertension.

摘要

本简短评论扩展了早期关于依从性价值的研究工作,以从处方药使用情况中得出医疗成本抵消估计值。在患有慢性血管疾病的老年人中,特定疾病药物使用量增加1%与非药房总医疗成本显著(P < 0.001)降低相关,血脂异常降低0.63%,充血性心力衰竭降低0.77%,糖尿病降低0.83%,高血压降低1.17%。

相似文献

1
Medical cost offsets from prescription drug utilization among Medicare beneficiaries.
J Manag Care Spec Pharm. 2014 Oct;20(10):994-5. doi: 10.18553/jmcp.2014.20.10.994.
2
Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Res Social Adm Pharm. 2010 Jun;6(2):100-9. doi: 10.1016/j.sapharm.2010.03.003. Epub 2010 May 7.
5
Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis.
J Manag Care Spec Pharm. 2015 Oct;21(10):956-64. doi: 10.18553/jmcp.2015.21.10.956.
6
Geographic variation in medication adherence in commercial and Medicare part D populations.
J Manag Care Spec Pharm. 2014 Aug;20(8):834-42. doi: 10.18553/jmcp.2014.20.8.834.
8
Digesting the doughnut hole.
J Health Econ. 2013 Dec;32(6):1345-55. doi: 10.1016/j.jhealeco.2013.04.007. Epub 2013 May 6.
9
Do interventions that address patient cost-sharing improve adherence to prescription drugs? A systematic review of recently published studies.
Expert Rev Pharmacoecon Outcomes Res. 2019 Jun;19(3):263-277. doi: 10.1080/14737167.2019.1567335. Epub 2019 Jan 24.
10
Medicare Beneficiaries Face Growing Out-Of-Pocket Burden For Specialty Drugs While In Catastrophic Coverage Phase.
Health Aff (Millwood). 2016 Sep 1;35(9):1564-71. doi: 10.1377/hlthaff.2016.0418.

引用本文的文献

3
Is it time to replace the star ratings adherence measures?
J Manag Care Spec Pharm. 2021 Mar;27(3):399-404. doi: 10.18553/jmcp.2021.27.3.399.
4
AMCP Nexus 2017 Highlights.
Am Health Drug Benefits. 2017 Dec;10(9):465-467.
5
Risk of Nondherence to Diabetes Medications Among Medicare Advantage Enrollees: Development of a Validated Risk Prediction Tool.
J Manag Care Spec Pharm. 2016 Nov;22(11):1293-1301. doi: 10.18553/jmcp.2016.22.11.1293.
6
Adherence to Metformin, Statins, and ACE/ARBs Within the Diabetes Health Plan (DHP).
J Gen Intern Med. 2015 Nov;30(11):1645-50. doi: 10.1007/s11606-015-3284-8. Epub 2015 May 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验